Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in Neurosci Lett Retrieve available abstracts of 64 articles: HTML format

Single Articles

October 2025
1. COLIN-MARTINEZ E, Arias C
   Intracerebral administration of Wnt7a improves memory performance and increases synaptophysin expression in the 3xTg-AD mouse model.
   Neurosci Lett. 2025;865:138336.
   PubMed     Abstract available
   
   
   August 2025
2. ZHANG T, E ED, Liu C, Li JW, et al
   Tropisetron modulates the firing activity of pyramidal and fast-spiking hippocampal CA1 neurons in a mouse model of Alzheimer's disease.
   Neurosci Lett. 2025 Aug 17:138360. doi: 10.1016/j.neulet.2025.138360.
   PubMed     Abstract available
   
   
   
3. MAURICE T
   Prevention of memory impairment and hippocampal injury with blarcamesine in an Alzheimer's disease model.
   Neurosci Lett. 2025 Aug 8:138349. doi: 10.1016/j.neulet.2025.138349.
   PubMed     Abstract available
   
   
   
4. LI Y, Gao Q, Zhuang C, Zhou Y, et al
   Modeling Alzheimer's disease in mice: Gonadectomy combined with bilateral hippocampus dentate gyrus injection of Abeta(1-42) oligomers.
   Neurosci Lett. 2025 Aug 5:138339. doi: 10.1016/j.neulet.2025.138339.
   PubMed     Abstract available
   
   
   
5. MAO YF, Chen L, Liu JY, Guo ZY, et al
   Intranasal insulin administration shows limited tau-targeted effects in early-stage APP/PS1 Alzheimer's mice.
   Neurosci Lett. 2025;865:138337.
   PubMed     Abstract available
   
   
   July 2025
6. WANG C, Li J, Liu Q, Yang R, et al
   Expression of concern: "Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-kappaB activation in a rat model of amyloid-beta-induced Alzheimer's disease" [NEUROSCI LETT, Volume 491 (2011) 127-132].
   Neurosci Lett. 2025;859-861:138254.
   PubMed    
   
   
   March 2025
7. YOKOYAMA K, Mukkatt J, Mathewson N, Fazzolari MD, et al
   Oligomer sensitive in-situ detection and characterization of gold colloid aggregate formations observed within the hippocampus of the Alzheimer's disease rat.
   Neurosci Lett. 2025 Mar 25:138218. doi: 10.1016/j.neulet.2025.138218.
   PubMed     Abstract available
   
   
   
8. TAHERI S, Paknejadi M, Esmaeili D, Ferdousi A, et al
   Studying the effect of Chlamydia trachomatis, Helicobacter pylori, and Varicella zoster microorganisms in stimulating the expression of cytokines TNFalpha, IFN?, TGFbeta, IL-10 in Alzheimer and non-Alzheimer patients.
   Neurosci Lett. 2025 Mar 9:138192. doi: 10.1016/j.neulet.2025.138192.
   PubMed     Abstract available
   
   
   
9. ZHANG C, Xu J, Xu F, Xie X, et al
   1-Epilupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice.
   Neurosci Lett. 2025;852:138184.
   PubMed     Abstract available
   
   
   February 2025
10. BHAGALOO KA, Yu L, West EA, Chandler DJ, et al
    Alterations in iron levels in the locus coeruleus of a transgenic Alzheimer's disease rat model.
    Neurosci Lett. 2025;850:138151.
    PubMed     Abstract available
    
    
    
11. MIKKELSEN JD, Linde-Atkins P, Pazarlar BA
    Higher level of [(3)H]UCB-J binding in ApoE E4 allele carriers with Alzheimer disease.
    Neurosci Lett. 2025;849:138135.
    PubMed     Abstract available
    
    
    November 2024
12. HU J, Liu X, Wang J, Yang Q, et al
    Improvement of olfactory function in AD mice mediated by immune responses under 40 Hz light flickering.
    Neurosci Lett. 2024;842:137958.
    PubMed     Abstract available
    
    
    
13. YANG X, Tohda C
    Diosgenin upregulates axonal guidance partner molecules, Galectin-1 and Secernin-1.
    Neurosci Lett. 2024;842:137954.
    PubMed     Abstract available
    
    
    October 2024
14. STYLA AM, Pitsikas N
    Joint administration of sub-threshold doses of the acetylcholinesterase inhibitor donepezil with those of the NMDA receptor antagonist ketamine improved rats' recognition memory abilities.
    Neurosci Lett. 2024;843:138026.
    PubMed     Abstract available
    
    
    
15. ANZALONE M, Karam SA, Briting SRR, Petersen S, et al
    Serotonin-2B receptor (5-HT(2B)R) expression and binding in the brain of APP(swe)/PS1(dE9) transgenic mice and in Alzheimer's disease brain tissue.
    Neurosci Lett. 2024 Oct 17:138013. doi: 10.1016/j.neulet.2024.138013.
    PubMed     Abstract available
    
    
    September 2024
16. HOJJATI SH, Butler TA, Luchsinger JA, Benitez R, et al
    Increased between-network connectivity: A risk factor for tau elevation and disease progression.
    Neurosci Lett. 2024;840:137943.
    PubMed     Abstract available
    
    
    August 2024
17. BAGHAEE P, Yoonesi M, Esfahani DE, Beirami E, et al
    Yttrium oxide nanoparticles alleviate cognitive deficits, neuroinflammation, and mitochondrial biogenesis impairment induced by streptozotocin.
    Neurosci Lett. 2024;837:137895.
    PubMed     Abstract available
    
    
    July 2024
18. LOZANO-TOVAR S, Nuccetelli M, Placidi F, Izzi F, et al
    CSF dynamics of orexin and beta-amyloid(42) levels in narcolepsy and Alzheimer's disease patients: A controlled study.
    Neurosci Lett. 2024 Jul 18:137914. doi: 10.1016/j.neulet.2024.137914.
    PubMed     Abstract available
    
    
    June 2024
19. CHITTORA R, Jain S, Roy A, Pandey S, et al
    Multifactorial effects of short duration early exposure low intensity magnetic field stimulation in Streptozotocin induced Alzheimer's disease rat model.
    Neurosci Lett. 2024;836:137878.
    PubMed     Abstract available
    
    
    
20. SMITH AS, Subramanian J, Doderer J, Moskovitz J, et al
    Methionine oxidation of clusterin in Alzheimer's disease and its effect on clusterin's binding to beta-amyloid.
    Neurosci Lett. 2024;836:137874.
    PubMed     Abstract available
    
    
    May 2024
21. TU Y, Xu B
    Esketamine induces tripartite motif-containing protein 24 to improve cognitive dysfunction in Alzheimer's disease.
    Neurosci Lett. 2024 May 25:137836. doi: 10.1016/j.neulet.2024.137836.
    PubMed     Abstract available
    
    
    
22. YANG C, Wu X, Feng J, Wu C, et al
    Clinical values of serum C5a in Alzheimer's disease patients with different dementia stages.
    Neurosci Lett. 2024 May 23:137833. doi: 10.1016/j.neulet.2024.137833.
    PubMed     Abstract available
    
    
    
23. FAZELINEJAD H, Zahedi E, Khadivi M
    Altering plasma lipids and liver enzyme activities via hippocampal injections of hen Lysozyme amyloid aggregates in an Alzheimer's disease mouse model: Insights into the therapeutic role of Bis (Indolyl) phenylmethane.
    Neurosci Lett. 2024;833:137825.
    PubMed     Abstract available
    
    
    
24. CHEN W, Zhang T, Zhang H
    Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease.
    Neurosci Lett. 2024;832:137816.
    PubMed     Abstract available
    
    
    
25. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Retraction notice to "Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model" [Neurosci. Lett. 783 (2022) 136702].
    Neurosci Lett. 2024 May 4:137793. doi: 10.1016/j.neulet.2024.137793.
    PubMed    
    
    
    April 2024
26. XIANG X, Xia S, Li S, Zeng Y, et al
    Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway.
    Neurosci Lett. 2024;830:137769.
    PubMed     Abstract available
    
    
    
27. ZHANG Y, Wu F
    Diagnostic value and cognitive regulatory roles of long non-coding RNA UCA1 in Alzheimer's disease.
    Neurosci Lett. 2024 Apr 5:137765. doi: 10.1016/j.neulet.2024.137765.
    PubMed     Abstract available
    
    
    March 2024
28. CHEN J, Su C, Ma Z, Ou X, et al
    Aerobic exercise suppresses cognitive injury in patients with Alzheimer's disease by regulating long non-coding RNA TUG1.
    Neurosci Lett. 2024;826:137732.
    PubMed     Abstract available
    
    
    
29. FENG Q, Li X, Liu R, Liu G, et al
    Overexpression of MTMR14 induced learning and memory impairments in 2-month-old C57 mice.
    Neurosci Lett. 2024;825:137700.
    PubMed     Abstract available
    
    
    February 2024
30. SHIGEMATSU K, Komori N, Ideno M, Yamagishi H, et al
    "Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".
    Neurosci Lett. 2024;825:137705.
    PubMed     Abstract available
    
    
    
31. HUANG W, Chen Q, Zhou P, Ye S, et al
    Neuroprotective effect of chrysophanol in Alzheimer disease via modulating the Ca(2+)/EGFR-PLCgamma pathway.
    Neurosci Lett. 2024 Feb 12:137684. doi: 10.1016/j.neulet.2024.137684.
    PubMed     Abstract available
    
    
    
32. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    PubMed     Abstract available
    
    
    
33. KAAR A, Weir MP, Rae MG
    Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca(2+) signaling in two rodent models of Alzheimer's disease.
    Neurosci Lett. 2024;823:137664.
    PubMed     Abstract available
    
    
    January 2024
34. XIE YH, Jiang L, Zhang Y, Deng YH, et al
    Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
    Neurosci Lett. 2024;820:137612.
    PubMed     Abstract available
    
    
    
35. ROBBIE L, Fernandez SG, Montoya L, Sagare A, et al
    Age of onset predicted by Abeta profiling in a novel PSEN1 (I180F) mutation.
    Neurosci Lett. 2024;820:137591.
    PubMed     Abstract available
    
    
    
36. CHEN TJ, Hung HS, Cheng TL, Wang DC, et al
    Histone deacetylase inhibitor attenuates the effects of 27-hydroxycholesterol on the rat brain.
    Neurosci Lett. 2024;818:137533.
    PubMed     Abstract available
    
    
    December 2023
37. ZHANG Y, Shen S, Li X, Wang S, et al
    A multiclass extreme gradient boosting model for evaluation of transcriptomic biomarkers in Alzheimer's disease prediction.
    Neurosci Lett. 2023;821:137609.
    PubMed     Abstract available
    
    
    November 2023
38. LIU L, Liu L, Lu Y, Zhang T, et al
    GDP dissociation inhibitor 1 (GDI1) attenuates beta-amyloid-induced neurotoxicity in Alzheimer's diseases.
    Neurosci Lett. 2023;818:137564.
    PubMed     Abstract available
    
    
    
39. ZARIFKAR AH, Zarifkar A, Safaei S
    Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimer's disease.
    Neurosci Lett. 2023 Nov 22:137570. doi: 10.1016/j.neulet.2023.137570.
    PubMed     Abstract available
    
    
    
40. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    PubMed     Abstract available
    
    
    
41. ZHANG J, Guo S, Tao R, Wang F, et al
    Neuroprotective effect of plasmalogens on AlCl(3)-induced Alzheimer's disease zebrafish via acting on the regulatory network of ferroptosis, apoptosis and synaptic neurotransmission release with oxidative stress as the center.
    Neurosci Lett. 2023;818:137560.
    PubMed     Abstract available
    
    
    October 2023
42. GHOLAMI A
    Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Neurosci Lett. 2023;817:137532.
    PubMed     Abstract available
    
    
    
43. KISHORE N, Goel N
    Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Neurosci Lett. 2023 Oct 17:137530. doi: 10.1016/j.neulet.2023.137530.
    PubMed     Abstract available
    
    
    September 2023
44. KAMRANFAR F, Jaktaji RP, Shirani K, Jamshidi A, et al
    Protective effect of a standardized Allium jesdianum extract in an Alzheimer's disease induced rat model.
    Neurosci Lett. 2023 Sep 19:137491. doi: 10.1016/j.neulet.2023.137491.
    PubMed     Abstract available
    
    
    August 2023
45. KARIMI-ZANDI L, Ghorbandaiepour T, Zahmatkesh M
    The increment of annexin V-positive microvesicles versus annexin V-negative microvesicles in CSF of an animal model of Alzheimer's disease.
    Neurosci Lett. 2023;814:137446.
    PubMed     Abstract available
    
    
    
46. BUDHBHATTI U, Joshi C, Chauhan A, Bhatt D, et al
    Association of NOTCH4 and ACHE gene polymorphism in Alzheimer's disease of Gujarat cohort.
    Neurosci Lett. 2023 Aug 4:137428. doi: 10.1016/j.neulet.2023.137428.
    PubMed     Abstract available
    
    
    July 2023
47. KUO YY, Chen WT, Lin GB, Chen YM, et al
    Thermal cycling-hyperthermia ameliorates Abeta(25-35)-induced cognitive impairment in C57BL/6 mice.
    Neurosci Lett. 2023;810:137337.
    PubMed     Abstract available
    
    
    
48. ABOLHASANI F, Pourshojaei Y, Mohammadi F, Esmaeilpour K, et al
    Exploring the potential of a novel phenoxyethyl piperidine derivative with cholinesterase inhibitory properties as a treatment for dementia: Insights from STZ animal model of dementia.
    Neurosci Lett. 2023;810:137332.
    PubMed     Abstract available
    
    
    
49. SHAJI S, Palanisamy R, Swaminathan R
    Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments.
    Neurosci Lett. 2023;810:137329.
    PubMed     Abstract available
    
    
    June 2023
50. NAKANISHI K, Norimatsu K, Tani A, Matsuoka T, et al
    Effects of early exercise intervention and exercise cessation on neuronal loss and neuroinflammation in a senescence-accelerated mouse prone 8.
    Neurosci Lett. 2023;808:137297.
    PubMed     Abstract available
    
    
    
51. CHEN L, Wang L, Zhou GF, Liu Y, et al
    TNIP2 inhibits amyloidogenesis by regulating the 3'UTR of BACE1: An in vitro study.
    Neurosci Lett. 2023;808:137265.
    PubMed     Abstract available
    
    
    
52. WANG M, Zhao H, Zhang Z, Zhao Z, et al
    Down-regulating insulin-like growth factor-1 receptor reduces amyloid-beta deposition in mice cortex induced by chronic sleep restriction.
    Neurosci Lett. 2023;808:137189.
    PubMed     Abstract available
    
    
    
53. HAMSAFAR Y, Chen Q, Borowsky AD, Beach TG, et al
    Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer's disease.
    Neurosci Lett. 2023 Jun 15:137330. doi: 10.1016/j.neulet.2023.137330.
    PubMed     Abstract available
    
    
    
54. DELVENNE JF, Scally B, Rose Burke M
    Splenium tract projections of the corpus callosum to the parietal cortex classifies Alzheimer's disease and mild cognitive impairment.
    Neurosci Lett. 2023;810:137331.
    PubMed     Abstract available
    
    
    April 2023
55. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    PubMed     Abstract available
    
    
    
56. RODRIGUEZ JJ, Terzieva S, Yeh CY, Gardenal E, et al
    Neuroanatomical and morphometric study of S100beta positive astrocytes in the entorhinal cortex during ageing in the 3xTg-Alzehimer's disease mouse model.
    Neurosci Lett. 2023;802:137167.
    PubMed     Abstract available
    
    
    
57. CAI Y, Fu P, Zhang X
    Association of plasma phosphor-tau181 with Abeta levels may vary by APOE epsilon4 status and sex among non-demented old adults.
    Neurosci Lett. 2023;802:137161.
    PubMed     Abstract available
    
    
    
58. SOMERA B, Frick M, Fadel JR
    Age-related changes in basal forebrain afferent activation in response to food paired stimuli.
    Neurosci Lett. 2023;802:137155.
    PubMed     Abstract available
    
    
    March 2023
59. XIONG L, Wang Z
    BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice.
    Neurosci Lett. 2023;801:137159.
    PubMed     Abstract available
    
    
    
60. WANG P, Wang X, Qiao K, Zhang Y, et al
    Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-beta.
    Neurosci Lett. 2023;799:137118.
    PubMed     Abstract available
    
    
    
61. SINGH L, Singh S
    Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Abeta ((1-42)) and NF-kB expression in experimental model of rats.
    Neurosci Lett. 2023;799:137090.
    PubMed     Abstract available
    
    
    
62. LI H, Zhang D, Wang X, Wang S, et al
    Protective effect of glutamic-oxaloacetic transaminase on hippocampal neurons in Alzheimer's disease using model mice.
    Neurosci Lett. 2023;803:137194.
    PubMed     Abstract available
    
    
    
63. WEI R, He JQ, Chen WH, Tam KY, et al
    Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2023 Mar 6:137166. doi: 10.1016/j.neulet.2023.137166.
    PubMed     Abstract available
    
    
    February 2023
64. PEREZ-GARCIA G, Bicak M, Haure-Mirande JV, Perez GM, et al
    BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT(P301S) mouse model of tauopathy.
    Neurosci Lett. 2023;797:137080.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.